Alto Neuroscience, Inc. - Common Stock, par value $0.0001 per share (ANRO)
CUSIP: 02157Q109
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / Common Stock, par value $0.0001 per share
- Shares outstanding
- 31,755,000
- Total 13F shares
- 26,830,701
- Share change
- +2,359,630
- Total reported value
- $602,479,913
- Put/Call ratio
- 3.4%
- Price per share
- $22.48
- Number of holders
- 110
- Value change
- +$54,953,807
- Number of buys
- 48
- Number of sells
- 52
Quarterly Holders Quick Answers
What is CUSIP 02157Q109?
CUSIP 02157Q109 identifies ANRO - Alto Neuroscience, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Previous quarter: Q4 2025
Recent filing periods for CUSIP 02157Q109:
Top shareholders of ANRO - Alto Neuroscience, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Commodore Capital LP |
13D/G
13F
|
Company |
9.9%
|
3,588,180
|
$77,791,742 | +$7,426,527 | 31 Mar 2026 | |
| Alpha Wave Global, LP |
13F
3/4/5
|
Company · 10%+ Owner |
12%
|
3,707,757
|
$65,998,075 | — | 31 Dec 2025 | |
| Point72 Asset Management, L.P. |
13F
13D/G
|
Company · Steven A. Cohen |
3.7%
from 13D/G
|
4,432,453
mixed-class rows
|
$64,883,188 | — | 31 Dec 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
2.1%
from 13D/G
|
4,468,395
mixed-class rows
|
$60,389,247 | — | 31 Dec 2025 | |
| Sirenia Capital Management LP |
13D/G
|
— |
7.9%
|
2,591,587
|
$56,185,606 | $0 | 31 Mar 2026 | |
| VANGUARD GROUP INC |
13F
|
Company |
—
mixed-class rows
|
3,802,680
mixed-class rows
|
$55,601,013 | — | 31 Dec 2025 | |
| PERCEPTIVE ADVISORS LLC |
13D/G
13F
|
Company |
10%
|
3,249,934
|
$53,623,911 | +$20,798,926 | 31 Dec 2025 | |
| ARMISTICE CAPITAL, LLC |
13F
13D/G
|
Company |
4.9%
from 13D/G
|
3,236,000
mixed-class rows
|
$49,168,800 | — | 31 Dec 2025 | |
| Vestal Point Capital, LP |
13D/G
13F
|
Company |
6.5%
|
2,064,075
|
$44,749,146 | -$9,125,654 | 31 Mar 2026 | |
| SYSTEMATIC FINANCIAL MANAGEMENT LP |
13F
|
Company |
6.1%
|
2,504,864
|
$32,162,463 | — | 31 Dec 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
—
mixed-class rows
|
1,472,533
mixed-class rows
|
$22,032,049 | — | 31 Dec 2025 | |
| Kevin Kotler |
13F
|
Individual |
4.1%
|
1,713,789
|
$21,997,218 | — | 31 Dec 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
—
mixed-class rows
|
1,167,937
mixed-class rows
|
$20,549,418 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
|
Company |
—
mixed-class rows
|
1,403,400
mixed-class rows
|
$18,667,754 | — | 31 Dec 2025 | |
| Vivo Capital, LLC |
13F
|
Company |
3.3%
|
1,035,551
|
$18,432,808 | — | 31 Dec 2025 | |
| WEBER CAPITAL MANAGEMENT LLC /ADV |
13F
|
Company |
3.4%
|
1,400,149
|
$17,977,913 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
—
mixed-class rows
|
1,257,333
mixed-class rows
|
$17,575,396 | — | 31 Dec 2025 | |
| Nuveen, LLC |
13F
|
Company |
3.1%
|
1,295,072
|
$16,628,724 | — | 31 Dec 2025 | |
| ROYCE & ASSOCIATES LP |
13F
|
Company |
3.1%
|
1,267,451
|
$16,274,071 | — | 31 Dec 2025 | |
| SEGALL BRYANT & HAMILL, LLC |
13F
|
Company |
2.9%
|
1,198,157
|
$15,384,336 | — | 31 Dec 2025 | |
| K2 HealthVentures Equity Trust LLC |
13D/G
|
— |
2.4%
|
788,995
|
$13,018,418 | -$13,676,190 | 31 Dec 2025 | |
| Bastion Asset Management Inc. |
13F
|
Company |
2.7%
|
1,118,180
|
$12,885,191 | — | 31 Dec 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
—
mixed-class rows
|
940,482
mixed-class rows
|
$12,558,888 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
—
mixed-class rows
|
779,494
mixed-class rows
|
$12,361,592 | — | 31 Dec 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
—
mixed-class rows
|
947,515
mixed-class rows
|
$12,321,333 | — | 31 Dec 2025 | |
| 72 Investment Holdings, LLC |
13F
|
Company |
2.1%
|
667,778
|
$11,886,448 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
—
mixed-class rows
|
748,567
mixed-class rows
|
$9,703,306 | — | 31 Dec 2025 | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP |
13F
|
Company |
1.8%
|
752,941
|
$9,667,762 | — | 31 Dec 2025 | |
| Ikarian Capital, LLC |
13F
|
Company |
1.6%
|
515,000
|
$9,167,001 | — | 31 Dec 2025 | |
| PARADIGM CAPITAL MANAGEMENT INC/NY |
13F
|
Company |
1.6%
|
678,200
|
$8,708,088 | — | 31 Dec 2025 | |
| ALKEON CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.5%
|
477,101
|
$8,492,398 | — | 31 Dec 2025 | |
| Phocas Financial Corp. |
13F
|
Company |
1.5%
|
606,273
|
$7,784,545 | — | 31 Dec 2025 | |
| Pier Capital, LLC |
13F
|
Company |
1.4%
|
571,855
|
$7,342,618 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
—
mixed-class rows
|
494,941
mixed-class rows
|
$7,317,485 | — | 31 Dec 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
—
mixed-class rows
|
477,797
mixed-class rows
|
$7,092,736 | — | 31 Dec 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
—
mixed-class rows
|
472,708
mixed-class rows
|
$6,844,912 | — | 31 Dec 2025 | |
| Integral Health Asset Management, LLC |
13F
|
Company |
1.2%
|
375,000
|
$6,675,000 | — | 31 Dec 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
—
mixed-class rows
|
445,177
mixed-class rows
|
$6,412,045 | — | 31 Dec 2025 | |
| DRIEHAUS CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.1%
|
336,762
|
$5,994,364 | — | 31 Dec 2025 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
—
mixed-class rows
|
390,101
mixed-class rows
|
$5,802,993 | — | 31 Dec 2025 | |
| Manatuck Hill Partners, LLC |
13F
|
Company |
1%
|
425,000
|
$5,457,000 | — | 31 Dec 2025 | |
| Connor, Clark & Lunn Investment Management Ltd. |
13F
|
Company |
0.96%
|
398,172
|
$5,112,528 | — | 31 Dec 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
—
mixed-class rows
|
342,088
mixed-class rows
|
$4,951,859 | — | 31 Dec 2025 | |
| ESSEX INVESTMENT MANAGEMENT CO LLC |
13F
|
Company |
0.87%
|
360,544
|
$4,629,385 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
—
mixed-class rows
|
334,685
mixed-class rows
|
$4,622,639 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
—
mixed-class rows
|
349,970
mixed-class rows
|
$4,578,252 | — | 31 Dec 2025 | |
| Peapod Lane Capital LLC |
13F
|
Company |
0.8%
|
253,992
|
$4,521,058 | — | 31 Dec 2025 | |
| AWM Investment Company, Inc. |
13F
|
Company |
0.71%
|
225,000
|
$4,005,000 | — | 31 Dec 2025 | |
| Spruce Street Capital LP |
13F
|
Company |
0.7%
|
222,844
|
$3,966,623 | — | 31 Dec 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
—
mixed-class rows
|
247,823
mixed-class rows
|
$3,460,000 | — | 31 Dec 2025 |
Institutional Holders of Alto Neuroscience, Inc. - Common Stock, par value $0.0001 per share (ANRO) as of Q1 2026
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.